Non-viral gene delivery system

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050170355A1
SERIAL NO

10513429

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns a composition comprising complexes of cationic chitosan oligomers derived from the cationic polysaccharide chitosan, wherein said cationic oligomers contain a weight fraction of less than 20% of oligomers with a Degree of Polymerization (DP)<10 in addition to a weight fraction of less than 20% with DP>50, and a nucleic acid. These compositions comprising well-defined cationic chitosan oligomers having a certain distribution of chain lengths, and nucleic acid are advantageous to achieve delivery of the nucleic acid into cells of a selected tissue, and to obtain in vivo expression of the desired molecules encoded for by the nucleic acid.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FMC BIOPOLYMER AS3013 DRAMMEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Artursson, Per Uppsala, SE 5 61
Christensen, Bjorn Erik Trondheim, NO 5 16
Koping-Hoggard, Magnus Uppsala, SE 4 16
Varum, Kjell Morten Trondheim, NO 9 32

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation